Gibson Dunn Guides St. Jude In $3.4B Deal For Thoratec
Medical device maker St. Jude Medical Inc. said Wednesday it has struck a deal guided by Gibson Dunn to buy Thoratec Corp. for $3.4 billion, expanding its heart failure treatment platform....To view the full article, register now.
Already a subscriber? Click here to view full article